Advanced Biomed Inc. Common Stock
ADVB · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $17 | $0 | $0 |
| % Growth | -100% | – | – | – |
| Cost of Goods Sold | $2 | $2 | $2 | $3 |
| Gross Profit | -$2 | -$2 | -$2 | -$3 |
| % Margin | – | -12.1% | – | – |
| R&D Expenses | $236 | $8 | $250 | $243 |
| G&A Expenses | $288 | $2,110,303 | $512 | $155 |
| SG&A Expenses | $288 | $2,110,303 | $512 | $155 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | -$2,110,273 | -$742 | -$385 |
| Operating Expenses | $524 | $37 | $21 | $13 |
| Operating Income | -$18 | -$39 | -$793 | -$559 |
| % Margin | – | -228.5% | – | – |
| Other Income/Exp. Net | $5 | $17 | -$591 | -$349 |
| Pre-Tax Income | -$13 | -$23 | -$1,384 | -$908 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$13 | -$23 | -$1,384 | -$908 |
| % Margin | – | -132.2% | – | – |
| EPS | -0.001 | -0.001 | -0.069 | -0.045 |
| % Growth | 45.5% | 98.4% | -52% | – |
| EPS Diluted | -0.001 | -0.001 | -0.069 | -0.045 |
| Weighted Avg Shares Out | 21,640 | 21,640 | 20,000 | 20,000 |
| Weighted Avg Shares Out Dil | 21,640 | 21,640 | 20,000 | 20,000 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $15 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $2 | $2 | $78 | $99 |
| EBITDA | -$11 | -$21 | -$685 | -$427 |
| % Margin | – | -120.1% | – | – |